Amino-tetralin derivatives as muscarinic receptor antagonists
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Oct 19, 2004
Grant Date -
May 13, 2004
app pub date -
Jun 27, 2003
filing date -
Dec 3, 2001
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
This invention relates to compounds which are generally muscarinic M2/M3 receptor antagonists and which are represented by Formula I: ##STR1## wherein R.sup.1, R.sup.2, R.sup.3 and R.sup.4 are as defined in the specification, or individual isomers, racemic or non-racemic mixtures of isomers, or acceptable salts or solvates thereof. The invention further relates to pharmaceutical compositions containing such compounds and methods for their use and preparation as therapeutic drugs.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully